Tuesday April 28, 2015   
Find us Facebook Follow us on Twitter Watch us on YouTube    
Donate Now
Brain Cancer Research Grants

Cutting-Edge Research Programs Only Possible with Your Support

These innovative research projects will have a monumental impact in regard to the treatment and diagnosis of brain cancer. Your donation helps scientists and doctors study various approaches that can one day eradicate brain cancer.

Click on a grant below to read more.


Led by Luiz Penalva at The University of Texas – San AntonioMore


Led by Viviane Tabar, MD at Memorial Sloan KetteringMore

Personalized Epigenetic Therapy For Treating Glioblastoma

Led by Jialiang Wang, PhD at Vanderbilt UniversityMore

Netrin-1: Novel Non-Invasive Biomarker and Therapeutic Target For Pediatric Brain Tumores

Led by Edward Smith, MD at Boston Children’s HospitalMore

Eradicating Brain Cancer Through Application of Cell-Penetrating Peptides Carrying Anti-Cancer Cargo

Led by James M. Angelastro at the University of California, DavisMore

Clinical Development of Type II EGFR Kinase Inhibitors for Glioblastoma

Led by Ingo K. Mellinghoff, MD at Memorial Sloaon-Kettering Cancer CenterMore

Development of Glioblastoma Cancer Stem Cell Inhibitor

Led by Santosh Kesari, MD/PhD at the University of California, San DiegoMore

Clinical development of a type II EGFR kinase inhibitor for glioblastomas

Led by Ingo K Mellinghoff, MD at Memorial Sloan Kettering CancerMore

Multifunctional EGFR Targeting Nanovehicles for the Treatment of Brain Tumors

Led by Rolf Barth, MD at Ohio State University More

Vaccination Against A Novel Survivan Epitope in Patients with Low Grade Glioma

Led by Hideho Okada, MD, PhD at the University of Pittsburgh Cancer Institute More

Interleaved Carbon Ion Minibeams to Treat Dogs with Spontaneous Malignant Glioma

Led by F. Avraham Dilmanian, Ph.D. at Brookhaven National Lab More

Characterizing the response of stem and progenitor like glioma cells to the chemoterhapeutic agent temozolomide

Led by Lindy Barrett, PhD at Memorial Sloan Kettering CancerMore

Phase I Clinical Trial of the IGF-1R Inhibitor, AXL1717, for Treatment of Recurrent Malignant Astrocytomas

Led by Robert Aiken, MD at Rush University Medical CenterMore

Whole Genome Sequencing of Pediatric Gangliogiomas

Led by Adam Resnick, Ph.D; Assistant Professor – Children’s Hospital of Philadelphia More

Dissecting the role of cdk4 and cyclin D1 in glioma – therapeutic implications

Led by Andrew Koff at Memorial Sloan Kettering CancerMore

Role of regulatory factor X1 in human gbm

Led by Zhiyi Zuo at University of VirginiaMore

A radiation activated prodrug nanoparticle platform for brain cancer therapy

Led by Milan Theodore Makale at University of California, San DiegoMore

Avoiding unnecessary toxicity and improving survival of children with low grade gliomas

Led by Simone Treiger Sredni, MD PhD at Ann & Robert Lurie Children’s HospitalMore

Tackling resistance to Bevacizumab therapy in GBMs

Led by Gabriele Bergers at University of California, San FranciscoMore

Preclinical evaluation of a Novel ERBB inhibitor optimized for CNS Biodistribution

Led by C. David James at University of California, San FranciscoMore

Characterization of hnRNP A2/B1 as a new oncogen in glioblastoma and its inhibition as a new therapy

Led by Rotem Karni at Hadassah Medical SchoolMore

Reprogramming iPSC Into Stem Cells, a possible turning point for cancer therapy

Led by Inan Olmez at Vanderbilt University Medical CenterMore

Develop a tumor-suppressive, extracellular, protein (TSEP) to treat GBM

Led by Yi-Hong Zhou, PhD at The Regents of the University of CaliforniaMore

Inhibitors of the PLD2-AKT signaling complex reveal a metabolic vulnerability in glioblastomas

Led by H Alex Brown at Vanderbilt University Medical CenterMore

Proteasomal control of glioblastoma cancer stem cell function

Led by Albert Kim, MD PhD at Washington University School of MedicineMore

Intraarterial delivery to the glioma stem cell niche

Led by John Boockvar, MD at Cornell UniversityMore

Role of miRNA-451 in the hypoxia-induced pro-angiogenic response of glioblastoma

Led by David Zagzag, MD, PhD at New York UniversityMore

Exosome therapy for brain tumors

Led by Xandra Breakefield, PhD at Harvard UniversityMore

Toxicity Profiling: Creating Novel Paradigms to Personalize Cancer Treatment

Led by Michael Scheurer at Baylor College of MedicineMore

Investigating cellular microparticles as biomarkers for glioblastoma growth and treatment

Led by Glenn Lesser, MD at Wake Forest School of Medicine

Actively Personalized vaccines for newly diagnosed gbm patients

Led by Hideho Okada, MD, PhD at University Of PittsburghMore

Identification and molecular analysis of circulating brain tumor cells

Led by Brian Vala Nahed at Massachusetts General HospitalMore

Pre-clinical testing of bacteriolytic therapy for gbm

Led by Gregory J. Riggins, MD, PhD at Johns Hopkins University More

Understanding the Multifaceted Role of the TNF-Alpha in Brain Tumors

Led by Ilan Volovitz at the The Tel-Aviv Sourasky Medical Center More



Interrogation of the Glioblastoma Exome to Overcome Therapy Resistance

Led by Claudia Petritch, PhD at University of California, San Francisco

Comprehensive Characterization of the Anaplastic Meningioma Genome

Led by Rameen Beroukhim, M.D., Ph.D. at the Dana Farber Cancer Institute More

Evaluating the Impact of Microenvironmental Elasticity on the Stem Cell Phenotype in Malignant Glioma

Led by Justin D. Lathia, Ph.D. at the Cleveland Clinic More

Convection-Enhanced Delivery of Ultrasmall nanoparticles loaded with Novel Drugs for Glioblastoma

Led by Jiangbing Zhou at the Yale University  More

Carboplatin Phase I Clinical Trials

Led by J. Bradley Elder, MD at the Department of Neurological Surgery at the Ohio State University Medical Center More

Microglia in Glioblastoma Invasion

Led by Marc Symons, PhD at the Center for Oncology and Cell Biology at The Feinstein Institute for Medical Research More

Personalized GBM Therapy using Notch and Akt Inhibition

Led by Xing Fan, MD PhD at the Department of Neurology at Regents of the University of Michigan More

Genetic Marker Clinical Trials

Led by Tracy Batchelor, MD, MPH at Massachusetts General Hospital/Harvard Medical School More

Stem Cell Neuro-Regeneration

Led by Henry Friedman, MD at Duke University Medical Center More

T-Cell Immunotherapy

Led by Laura Johnson, PhD at Duke University Medical Center More

Glioma Cell Migration and Invasion

Led by Steven Rosenfeld, MD, PhD at New York-Presbyterian Hospital/Columbia University Medical Center More

Nanoparticle-Based Therapy

Led by Joseph Piepmeier, MD at Yale School of Medicine More

Drug Clinical Trials

Led by Andrew B. Lassman, MD at Memorial Sloan-Kettering Cancer Center More

Chemotherapy Coils

Led by Susan C. Pannullo, MD at New York-Presbyterian Hospital/Weill Cornell Medical Center More

Young Investigators

Led by Dr. Jeffrey Raizer and Dr. Marcus Bredel at Northwestern University More

Clinical Trials

Led by Steven S. Rosenfeld, MD, PhD at New York-Presbyterian Hospital/Columbia University’s Brain Tumor Center More

For Researchers

To apply for a brain cancer research grant, click here to read our guidelines and access our grant application.






We look forward to continuing to fund innovative programs in brain cancer research and support. If you are interested in sponsoring a research grant, please contact Darren Port at 646.278.6735.





Voices Against Brain Cancer is a not-for-profit public charity recognized by the IRS under 501 (c) (3)